Arroyo, PR, United States of America

Pedro E HErnandez-Abad

This inventor holds 1 USPTO granted patent. Top assignee: Can-Fite Biopharma Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pedro E HErnandez-Abad. Retrieved from https://idiyas.com/inventor/pedro-e-hernandez-abad-df0kja7d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pedro E Hernandez-Abad: Innovator in Pharmaceutical Synthesis

Introduction

Pedro E Hernandez-Abad is a notable inventor based in Arroyo, Puerto Rico. He has made significant contributions to the field of pharmaceutical synthesis, particularly through his innovative methods.

Latest Patents

Hernandez-Abad holds a patent for a process titled "Process for the synthesis of IB-MECA." This patent outlines a method for synthesizing IB-MECA, emphasizing a simple and high-yield approach suitable for Good Manufacturing Production (GMP). The method involves several key steps, including the reaction of 6-halopurine-9-riboside with a diol protecting reagent, oxidation of the primary alcohol, and subsequent reactions leading to the final product.

Career Highlights

Hernandez-Abad is associated with Can-Fite Biopharma Ltd., where he applies his expertise in pharmaceutical development. His work focuses on enhancing the efficiency and effectiveness of drug synthesis processes.

Collaborations

He collaborates with esteemed colleagues such as Paul Bruzinski and Xuejun Karl Liu, contributing to a dynamic research environment that fosters innovation.

Conclusion

Pedro E Hernandez-Abad's contributions to pharmaceutical synthesis exemplify the impact of innovative thinking in the field. His patent for the synthesis of IB-MECA showcases his commitment to advancing drug development processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…